Mutation analysis of the Smad3 gene in human osteoarthritis

European Journal of Human Genetics

Volumn 11, Issue 9, 2003, Pages 714-717

  Yao, Jun Yan ^a,b   Wang, Yan ^c   An, Jing ^b   Mao, Chun Ming ^a   Hou, Ning ^a   Lv, Ya Xin ^a   Wang, You Liang ^a   Cui, Fang ^a   Huang, Min ^c   Yang, Xiao ^a  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Mutation; Osteoarthritis; PCR SSCP; Smad3 gene

Indexed keywords

ADENINE; ASPARAGINE; GELATINASE A; GELATINASE B; ISOLEUCINE; SMAD3 PROTEIN; THYMINE;

AMINO ACID SUBSTITUTION; ARTHROPATHY; ARTICLE; BLOOD LEVEL; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; FRACTURE; GENE DISRUPTION; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENE TARGETING; GENETIC SCREENING; HETEROZYGOTE; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NUCLEIC ACID BASE SUBSTITUTION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; ELECTROPHORESIS; GENE EXPRESSION; HUMANS; MATRIX METALLOPROTEINASE 2; MUTATION, MISSENSE; OSTEOARTHRITIS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE ANALYSIS, DNA; SMAD3 PROTEIN; TRANS-ACTIVATORS;

EID: 0141701927     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201034     Document Type: Article

References (19)

1. Jordan JM, Kington RS, Lane NE et al: Systemic risk factors for osteoarthritis; In Felson DT (conference chair): Osteoarthritis: new insights. Part 1: The disease and its risk factors. Ann Intern Med 2000; 133: 637-639.
2. Reginster JY: The prevalence and burden of arthritis. Rheumatology 2002; 41(suppl 1): 3-6.
3. Zeng Q, Huang S, Xiao Z et al: Osteoarthritis: clinical and epidemiological investigation. Chin J Internl Med 1995; 34: 88-90.
4. Zhang N, Shi Q, Zhang X et al: Epidemiological investigation of osteoarthritis. Chin J Intern Med 1995; 34: 84-87.
5. Massague J: TGF-β signal transduction. Annu Rev Biochem 1998; 67: 753-791.
6. Yang X, Letterio JJ, Chen L et al: Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β. EMBO J 1999; 18: 1280-1291.
7. Yang X, Chen L, Xu L et al: TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. Journal of Cell Biology 2001; 153: 35-46.
8. Arai T, Akiyama Y, Okabe S et al: Genomic structure of the human Smad3 gene and its infrequent alterations in colorectal cancers. Cancer Lett 1998; 122: 157-163.
9. Kleiner DE, Stetler-Stevenson WG: Quantitative zymography: detection of picogram quantities of gelatinase. Anal Biochem 1994; 218: 325-329.
10. Tanaka A, Kumagai S, Kawashiri S et al: Expression of matrix metalloproteinase-2 and -9 in synovial fluid of the temporomandibular joint accompanied by anterior disc displacement. J Oral Pathol Med 2001; 30: 59-64.
11. Yamada Y, Okuizumi H, Miyauchi A et al: Association of transforming growth factor beta1 genotype with spinal osteophytosis in Japanese women. Arthritis Rheum 2000; 43: 452-460.
12. Micheal W, Yang X, Deng C: Functions of mammalian Smad genes as revealed by targeted gene disruption in mice. Cytokine Growth Factor Rev 2000; 11: 49-58.
13. Bevan S, Woodford-Richens K, Rozen P et al: Screening SMAD1, SMAD2, SMAD3, and SMAD5 for germline mutations in juvenile polyposis syndrome. Gut 1999; 45: 406-408.
14. Wang D, Kanuma T, Takama F et al: Mutation analysis of the Smad3 gene in human ovarian cancers. Int J Oncol 1999; 15: 949-953.
15. Giggins GJ, Kinzler KW, Vogelstein B et al: Frequency of Smad gene mutations in human cancers. Cancer Res 1997; 57: 2578-2580.
16. Osawa H, Shitara Y, Shoji H et al: Mutational analysis of transforming growth factor β type II receptor, Smad2, Smad3 and Smad4 in esophageal squamous cell carcinoma. Int J Oncol 2000; 17: 723-728.
17. Kretzschmar M, Doody J, Massague J: Opposing BMP and EGF signaling pathways converge on the TGF-β family mediator Smad1. Nature 1997; 389: 618-622.
18. Miyazaki Y, Tsukazaki T, Hirota Y et al: Dexamethasone inhibition of TGF beta-induced cell growth and type II collagen mRNA expression through ERK-integrated AP-1 activity in cultured rat articular chondrocytes. Osteoarthritis Cartilage 2000; 8: 378-385.
19. Wu Y, Feng Y, Yang X et al: TGF-β1 mediated by SMAD3 inhibits the expression of MMP9 in COS7 cells. Chin J Biochem Mol Biol 2002; 18: 684-687.